Real-Life Management of Elevated Troponin Level in Patients Treated with Immune Checkpoint Inhibitors

Real-Life Management of Elevated Troponin Level in Patients Treated with Immune Checkpoint Inhibitors

Background: Immune checkpoint inhibitors (ICIs) have revolutionized the clinical outcomes of cancer. Nevertheless, their use may lead to myocardial injury. The 2022 European Society of Cardiology cardio-oncology guidelines recommend routine follow-up of troponin level; however, current guidelines do...

Full description

Saved in:
Bibliographic Details
Main Authors: Lior Zornitzki, MD, Dana Viskin, MD, Ophir Freund, MD, Ido Wolf, MD, Anna Rozenfeld Hemed, MD, Noam Weiss, MS, Shir Frydman, MD, Ms, Maor Tzuberi, MS, Shafik Khoury, MD, Ofer Havakuk, MD, Yan Topilsky, MD, Shmuel Banai, MD, Michal Laufer-Perl, MD, MHA
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X25001039
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items